- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
No advantage of Atropine addition to soft multifocal contact lens for myopia correction in kids
![No advantage of Atropine addition to soft multifocal contact lens for myopia correction in kids No advantage of Atropine addition to soft multifocal contact lens for myopia correction in kids](https://medicaldialogues.in/h-upload/2022/03/23/750x450_172776-download-2022-03-24t021908491.webp)
Addition of 0.01% atropine to soft multifocal contact lens failed to correct myopia, according to a new study. Combining 0.01% atropine with soft multifocal contact lenses (SMCL) failed to demonstrate better myopia control than soft multifocal contact lenses (SMCL) alone.
The study has been published in Optometry and Vision Science.
The Bifocal & Atropine in Myopia (BAM) study investigated whether combining 0.01% atropine and soft multifocal contact lenses (SMCL) with +2.50-D add power leads to greater slowing of myopia progression and axial elongation than SMCL alone.
BAM participants wore SMCL with +2.50-D add power daily and were administered 0.01% atropine eye drops nightly (n = 46). The BAM subjects (Bifocal + Atropine) were age-matched to 46 participants in the Bifocal Lenses In Nearsighted Kids (BLINK) Study who wore SMCL with +2.50-D add (Bifocal) and 46 BLINK participants who wore single vision contact lenses (Single Vision). The primary outcome was the 3-year change in spherical equivalent refractive error determined by cycloplegic autorefraction, and the 3-year change in axial elongation was also evaluated.
Results:
Of the total 138 subjects, the mean age was 10.1 ± 1.2 years and the mean spherical equivalent was -2.28 ± 0.89 D. The 3-year adjusted mean myopia progression was -0.52 D for Bifocal + Atropine, -0.55 D for Bifocal, and -1.09 D for Single Vision. The difference in myopia progression was 0.03 D (95% CI, -0.14 to 0.21) for Bifocal + Atropine vs Bifocal and 0.57 D (95% CI, 0.38-0.77) for Bifocal + Atropine vs Single Vision. The 3-year adjusted axial elongation was 0.31 mm for Bifocal + Atropine, 0.39 mm for Bifocal, and 0.68 mm for Single Vision. The difference in axial elongation was -0.08 mm (95% CI, -0. 16 to 0.002) for Bifocal + Atropine vs Bifocal and -0.37 mm (95% CI, -0.46 to -0.28) for Bifocal + Atropine vs Single Vision.
Thus, adding 0.01% atropine to soft multifocal contact lenses (SMCL) with +2.50-D add power failed to demonstrate better myopia control than soft multifocal contact lenses (SMCL) alone.
Reference:
Effect of Combining 0.01% Atropine with Soft Multifocal Contact Lenses on Myopia Progression in Children by Jones, Jenny Huang et al. published in Optometry and Vision Science.
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751